Details

Autor(en) / Beteiligte

• Ago, Yukio
• Yano, Koji
• Araki, Ryota
• Hiramatsu, Naoki
• Kita, Yuki
• Kawasaki, Toshiyuki
• Onoe, Hirotaka
• Chaki, Shigeyuki
• Nakazato, Atsuro
• Hashimoto, Hitoshi
• Baba, Akemichi
• Takuma, Kazuhiro
• Matsuda, Toshio

Titel

Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice

Ist Teil von

• Neuropharmacology, 2013-02, Vol.65, p.29-38

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Metabotropic glutamate 2/3 (mGlu2/3) receptor antagonists have an antidepressant-like effect, but the exact mechanism still remains unclear. This study examined the effects of mGlu2/3 receptor antagonists in chronic corticosterone-treated mice which could be used as an animal model of depression. In the forced swim test, the mGlu2/3 receptor antagonists MGS0039 (1.0 mg/kg, i.p.) and LY341495 (0.3 mg/kg, i.p) significantly reduced the increased immobility time of mice pretreated with corticosterone (20 mg/kg, s.c.) for 21 days, while desipramine (30 mg/kg, i.p.) and fluoxetine (30 mg/kg, i.p.) did not. The antidepressant-like effect of LY341495 was not blocked by the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonist NBQX (10 mg/kg, i.p.). Systemic administration of LY341495 did not affect basal release of glutamate, dopamine or serotonin in the prefrontal cortex of the control or chronic corticosterone-treated mice. Chronic corticosterone markedly enhanced high K+-induced release of dopamine, but not serotonin or glutamate, in the prefrontal cortex. This neurochemical change was blocked by systemic administration of MGS0039 and LY341495, but not desipramine or fluoxetine. These results suggest that chronic corticosterone-treated mice could be used as an animal model of treatment-resistant depression. This study also suggests that the prefrontal dopaminergic system is involved in the antidepressant-like effect of mGlu2/3 receptor antagonists in the chronic corticosterone-induced depression model. ► Chronic corticosterone-treated mice could be used as an animal model of depression. ► In this model, mGlu2/3 receptor antagonists showed an antidepressant-like effect. ► The effect of an mGlu2/3 receptor antagonist was not blocked by the AMPA receptor antagonist. ► The high K+-induced prefrontal dopamine release was blocked by the mGlu2/3 receptor antagonists. ► The dopamine system is involved in the antidepressant-like effect of mGlu2/3 receptor antagonists.